Technology | Computed Tomography (CT) | April 18, 2018

FDA Clears Siemens' Somatom go.All, go.Top CT Scanners

Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT

FDA Clears Siemens' Somatom go.All, go.Top CT Scanners

April 18, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Somatom go.All and Somatom go.Top computed tomography (CT) systems from Siemens Healthineers. These additions to the company’s go. CT platform expand its concept of patient-centric mobile workflow, which is controlled via tablet and remote, into advanced clinical fields and applications such as cardiology, CT-guided intervention and dual energy CT.

With a 0.33-second rotation time, Stellar detector technology and a 75 kW generator, the 64-slice Somatom go.All meets a wide range of clinical needs. The 128-slice Somatom go.Top leverages the same technologies as well as a large detector to deliver an acquisition speed of up to 175 mm in one second, making it ideal for trauma scanning. Interventional procedures benefit from Guide&Go, what Siemens calls the first tablet-based solution for CT-guided interventions, which enables the interventional radiologist to use traditional touch features rather than a joystick for more precise image manipulation.

The new Athlon X-ray tube at the heart of both systems permits personalized dose optimization due to the tube’s ability to offer high mA at low kV. Users can adjust tube voltage in 10-kV increments while keeping tube current high. CARE kV technology removes the guesswork when adjusting dose parameters. An alternative to cumbersome injector mounting options, the gantry-mounted injector arm enables flexible arrangement of the contrast injector, making for a more organized working environment. Additionally, Somatom go.Top offers TwinBeam Dual Energy imaging for simultaneous examination of the same region at two different energy levels. Information from the resulting two image datasets is particularly beneficial in virtual non-contrast, gout, contrast enhancement, soft tissue differentiation, lesion characterization and oncology applications.

Each of the four scanners in the Somatom go. CT platform uses GO technologies such as Recon&GO to reduce the time a technologist spends on manual and repetitive reconstruction tasks. The platform enables zero-click reconstructions for even highly complex procedures such as coronary CT angiography and TwinBeam Dual Energy, helping the technologist remain close to – and focus on – patients.

For more information: www.usa.healthcare.siemens.com

 

Related Content

Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data

Figure 1: Depiction of the fully automated CT biomarkers tools used in this study. (A) Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data. (B) Case example in an asymptomatic 52-year-old man undergoing CT for colorectal cancer screening. At the time of CT screening, he had a body-mass index of 27·3 and Framingham risk score of 5% (low risk). However, several CT-based metabolic markers were indicative of underlying disease. Multivariate Cox model prediction based on these three CT-based results put the risk of cardiovascular event at 19% within 2 years, at 40% within 5 years, and at 67% within 10 years, and the risk of death at 4% within 2 years, 11% within 5 years, and 27% within 10 years. At longitudinal clinical follow-up, the patient suffered an acute myocardial infarction 3 years after this initial CT and died 12 years after CT at the age of 64 years. (C) Contrast-enhanced CT performed 7 months before death for minor trauma was interpreted as negative but does show significant progression of vascular calcification, visceral fat, and hepatic steatosis. HU=Hounsfield units.

News | Cardiac Imaging | March 06, 2020
March 6, 2020 — Researchers at the National Institutes of Health a
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along with eight other...
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Cardiac Imaging | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve).

At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve). Photo by Greg Freiherr

Feature | Cardiac Imaging | March 22, 2019 | By Greg Freiherr
Reflecting a trend toward the increased use of ...
SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram.

SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram. Results from an international study presented at #ACC19 show that pressure readings in coronary arteries may identify locations of stenoses remaining after cardiac cath interventions.

Feature | Cardiac Imaging | March 18, 2019 | By Greg Freiherr
As many as one in four patients who undergo cath lab interventions can benefit from a technology that identifies the
Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Feature | Cardiac Imaging | March 17, 2019 | By Greg Freiherr
Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applica
Overlay Init